Interestingly, administration of the URAT1 inhibitor dotinurad in mice improves hepatic steatosis and insulin resistance induced by a high-fat diet, highlighting the potential role of URAT1 in regulating glucose metabolism (Tanaka et al., 2022). This evidence concerns the gene SLC22A12 and fatty liver disease.